[
  {
    "title": "Activist hedge fund builds stake in Ozempic-maker Novo Nordisk - Financial Times",
    "link": "https://news.google.com/rss/articles/CBMicEFVX3lxTE5qWElZc3EwZWlwTWNKdHFZWHluX3NLT0t4YXFuSHU1bVo1SWV0TWNubERtS0pQRFRISVZYSkZNNGdfOTZwX2VJMXpPOHVubm1lQ0g0ZnFqY1A2ZGNuZmZmVktWeWNEcjJWRGpXNzRaRWE?oc=5",
    "published": "Mon, 09 Jun 2025 16:55:16 GMT",
    "source": "Financial Times",
    "summary": "Activist hedge fund builds stake in Ozempic-maker Novo Nordisk. Financial Times reports that the fund has invested in the Danish company. The fund has also invested in Danish drugmaker Telegraaf, according to reports.",
    "company_type": "client",
    "category": "1. Investments, M&A and Partnerships"
  },
  {
    "title": "Eli Lilly looks set to steal Novo Nordisk\u2019s weight-loss crown - The Economist",
    "link": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNYjNZS0swVEV5MGRhTGx2RjRwTW82R2s1TGMwQkI1ZEYtSENmWVhBTk5SaHVTVEJBdlJqV0ZVWFN5QzYyRnhsRVFvcXRsTmtLRXU2cHF2ME9lLVNVTGdOdk9BbnRHWFRuZkl5STU3ZHEtamRQZzlRa19hNkZkZjlwTmRZS3FPOC1Bc1djQnF1QUhjdDh1dWJSTlZ2SDVYRUx2ajcxTDVpRkU4UQ?oc=5",
    "published": "Wed, 07 May 2025 07:00:00 GMT",
    "source": "The Economist",
    "summary": "Eli Lilly looks set to steal Novo Nordisk\u2019s weight-loss crown - The Economist. The drug giant is set to launch a new range of obesity-lowering drugs.",
    "company_type": "client",
    "category": "Strategy and Management"
  },
  {
    "title": "FDA Launches AI Initiative to Streamline Drug Reviews as Novo Nordisk Faces Rising Competition in Obesity Treatments - geneonline.com",
    "link": "https://news.google.com/rss/articles/CBMi3wFBVV95cUxNNFFwbXlPU0ZYdXNmOXlzY0FJZl80bVBLVzZ5ZmswVWVLMk12Qzk4c3YxUWp1YnV6RjE4TjNObWJpWDNTUTliTUpXUVh6RE44bDg3cWtLRWlVaVJZaU9EaGpmX1dKa2NzMTRoSDJrMVJIRGpMVTVIMXFtYnplZUVIc0RMcTJpWEgySFowLVlQRXkteWJGY2JIN0JpOTNGM3RLN1RfYUJIUXpuYkdXVkFNcnhLM2tjLW9Ka0hORm1DVjctQmg4YlYzemYzaGJiOXlXVGVBUkZ4X2RGcmZYckZv?oc=5",
    "published": "Mon, 16 Jun 2025 19:03:09 GMT",
    "source": "geneonline.com",
    "summary": "FDA Launches AI Initiative to Streamline Drug Reviews as Novo Nordisk Faces Rising Competition in Obesity Treatments - geneonline.com. FDA launches new initiative to streamline drug reviews.",
    "company_type": "client",
    "category": "1. Strategy and Management"
  },
  {
    "title": "Novo Nordisk fast-tracks oral, SC amycretin into late-stage weight-loss testing - FirstWord Pharma",
    "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE9oUnU0Z2paLTF5REFJSE1QNlpScXQ0MFVPcDZzczU5bFMzdDRTdHVDWWhqTUdGN1FwVHVDYnc4dFY5ckdGNVItT0lUdi1ydUZHS0lB?oc=5",
    "published": "Thu, 12 Jun 2025 18:41:27 GMT",
    "source": "FirstWord Pharma",
    "summary": "Novo Nordisk fast-tracks oral, SC amycretin into late-stage weight-loss testing. FirstWord Pharma. First Word Pharma is a division of Novo Nordisk.",
    "company_type": "client",
    "category": "Strategy and Management"
  },
  {
    "title": "Novo Nordisk starts new CagriSema weightloss drug trial - Reuters",
    "link": "https://news.google.com/rss/articles/CBMixgFBVV95cUxPNDFsUXJJV1BFWjIzc2tWNmJaUVJXelNDel9lY2ZHMm10SFdjZk10eVVOcHpCMHc0SFNya2l2OE9rRW51bTVfMHlTR2czRmFSQm1qdm9RRkdvc1RSQm1pWExoN3QzODZYOXFISTlVRkUtaTJtckt1Mm1qd0poeDk2TjF6QmtrdTMtUU8wWnRoamI5OWxqU0g2WC1iR0NpVnFxbHJPaXM1WXg2elZNTzRKdkJGOXNuRnJHc084cXFheVYzcjNNbVE?oc=5",
    "published": "Tue, 10 Jun 2025 17:01:43 GMT",
    "source": "Reuters",
    "summary": "Novo Nordisk starts new CagriSema weightloss drug trial - Reuters. News agency reports that Novo Nordisk is testing a new drug for weight loss. The drug is being developed by Novo's subsidiary, NovoNordisk.",
    "company_type": "client",
    "category": "1. Strategy and Management"
  },
  {
    "title": "Novo Nordisk, FDA Score Win in Weight Loss Drug Shortage Fight - Bloomberg Law News",
    "link": "https://news.google.com/rss/articles/CBMitgFBVV95cUxOSUZEVmNnY0NNZWhUVmpVSTctdGtFT1ltVWVLZXZJRnJJY040WElObURhWlJGX3FNNndscHIzWjZROFB1WEE4VE1jMEFITVphWHF0NjU0QkZBeTdOUWY2aUdTc05nbVUyeVc4S1BwU01IblR1U0FRbE95NkRyMUp4aGcxbDBsTWZHRGlMTzF4ZFhuZWk5cmY0SlotSm1SeUxia3MzanVUYTY2SnJMd1I0TzQ1MnN2dw?oc=5",
    "published": "Mon, 16 Jun 2025 16:06:00 GMT",
    "source": "Bloomberg Law News",
    "summary": "Novo Nordisk, FDA Score Win in Weight Loss Drug Shortage Fight. Bloomberg Law News: Novo Nordisk wins weight loss drug battle with Merck, Pfizer, GlaxoSmithKline.",
    "company_type": "client",
    "category": "Strategy and Management"
  },
  {
    "title": "After ousting CEO, Novo Nordisk reclaims crown as largest European company - MarketWatch",
    "link": "https://news.google.com/rss/articles/CBMitwFBVV95cUxNdGpPYjZ1OWlrZlY4ODBDMDVjYW9oWHM1azZ5Q2JpS0JjSmhuejE1bmtYV2l6ZVFEVFJGWDJkMlU5X2Y4N1Vxc2pteHpVSHFPeVdXZTZQakVXMXk3RlZpNWw4XzAycVo4RVBqLXg0YlcyWW0xZEtwX0NMd3JKNDZGTUxFLS1xeVJoSEhhSFM5MHpRbzd4dzFiRHJHYUFna2IzWl9KN3d4N3RFWUswSHRNUHJLV2ZTVHM?oc=5",
    "published": "Fri, 13 Jun 2025 11:14:00 GMT",
    "source": "MarketWatch",
    "summary": "After ousting CEO, Novo Nordisk reclaims crown as largest European company - MarketWatch. After ousting CEOs, the Danish company is now the world's largest drugmaker.",
    "company_type": "client",
    "category": "1. Strategy and Management"
  },
  {
    "title": "Novo Nordisk Foundation CEO wants to help US researchers relocate to Europe - medwatch.com",
    "link": "https://news.google.com/rss/articles/CBMib0FVX3lxTE11VURGRjB2amlKeVBPUUh2Y2VUdEpIeGpvRTNjS2dubnVacjhaUHF6dXUxTG1Obkk2a2doVU5MdjBLX3lodU1sVE8yVzBwYlJoRnNqdGR0NlhmeGdjWlFXWlI1bUExVWdZaWp0eTFWYw?oc=5",
    "published": "Mon, 16 Jun 2025 06:59:00 GMT",
    "source": "medwatch.com",
    "summary": "Novo Nordisk Foundation CEO wants to help US researchers relocate to Europe - medwatch.com. Nordea CEO wants US researchers to move to Europe to work in the Nordic region.",
    "company_type": "client",
    "category": "6. ESG and Sustainability"
  }
]